NGL(SZ:002836)2024-08-29 08:37Financial Performance - The company's operating revenue for the first half of 2024 reached ¥153,085,493.90, representing a 192.38% increase compared to ¥52,358,437.19 in the same period last year[10]. - Net profit attributable to shareholders was ¥28,240,240.19, a significant increase of 1,063.48% from ¥2,427,214.55 in the previous year[10]. - The net profit after deducting non-recurring gains and losses was ¥25,953,522.50, up 5,753.97% from ¥443,349.14 in the same period last year[10]. - The net cash flow from operating activities was ¥80,486,311.68, a turnaround from a negative cash flow of ¥14,067,941.44 in the previous year, marking a 672.13% improvement[10]. - Basic and diluted earnings per share both increased to ¥0.12, up 1,100.00% from ¥0.01 in the same period last year[10]. - The weighted average return on equity rose to 7.37%, compared to 0.56% in the previous year, an increase of 6.81 percentage points[10]. - Total operating revenue for the first half of 2024 reached CNY 153,085,493.90, a significant increase from CNY 52,358,437.19 in the same period of 2023, representing a growth of approximately 192.3%[93]. - Operating profit for the first half of 2024 was CNY 32,536,494.98, compared to CNY 2,617,612.19 in the first half of 2023, indicating a substantial increase of about 1,143.5%[93]. - The total profit for the first half of 2024 was CNY 32,526,495.08, a significant increase from CNY 2,627,779.69 in the same period of 2023, indicating a growth of approximately 1,137.5%[93]. Revenue and Growth - The report highlights significant growth in both revenue and profit, indicating a strong recovery and operational efficiency[10]. - The company reported a significant increase in orders during the reporting period, driving substantial revenue growth[19]. - The total operating revenue from the packaging printing medical supplies segment was ¥151,708,265.19, which constituted 99.10% of total revenue, reflecting a 198.90% increase year-on-year[30]. - The company reported a significant increase in sales in the Southwest region, with revenue reaching ¥123,489,009.41, a 379.86% increase from the previous year[30]. Costs and Expenses - Operating costs increased to ¥102,733,128.47, a rise of 154.91% from ¥40,302,046.22, primarily due to the increase in revenue[29]. - Research and development expenses rose to ¥6,237,456.82, marking a 70.96% increase from ¥3,648,488.70, indicating a focus on innovation[29]. - The company reported a total operating cost of CNY 122,314,514.48 for the first half of 2024, compared to CNY 52,924,954.52 in the same period of 2023, which is an increase of approximately 131.1%[93]. Assets and Liabilities - Total assets at the end of the reporting period were ¥491,525,428.88, a 2.57% increase from ¥479,211,078.40 at the end of the previous year[10]. - Current assets totaled CNY 320,443,877.04, slightly up from CNY 317,841,121.42, indicating a marginal increase of about 0.51%[86]. - The total liabilities increased to CNY 152,869,887.88 from CNY 103,297,636.26, indicating a growth of approximately 47.9%[91]. - The total equity attributable to shareholders decreased to CNY 353,937,360.21 from CNY 388,223,555.92, reflecting a decline of approximately 8.8%[91]. Environmental and Social Responsibility - The company is listed as a key pollutant discharge unit in Chaozhou for 2024, adhering to strict emission standards without exceeding limits[44]. - The company has invested CNY 695,735.12 in environmental governance during the first half of 2024[46]. - The company maintains a commitment to social responsibility, focusing on creating value for stakeholders and ensuring sustainable development[49]. - During the reporting period, the company actively participated in local social welfare initiatives, including tree planting activities, contributing to community development[53]. Research and Development - The company has invested in R&D and innovation, collaborating with universities to enhance its design and production capabilities[24]. - The company focuses on high-stability, high-technology, and high-value-added cigarette label products, providing comprehensive services from pre-press to post-press[16]. - Research and development expenses for the first half of 2024 amounted to CNY 6,237,456.82, compared to CNY 3,648,488.70 in the previous year, marking an increase of about 71.2%[93]. Market Position and Competition - The company has established partnerships with major tobacco companies, including Yunnan Tobacco and Zhejiang Tobacco, enhancing its market position[15]. - The company has developed a strong competitive advantage through customer resource accumulation and large-scale production capabilities[21]. - The company is addressing intensified market competition from new tobacco products by leveraging its experience and quality to maintain customer relationships and explore new markets[39]. Financial Management and Compliance - The company has not engaged in any significant asset or equity sales during the reporting period[38]. - The company has not reported any environmental accidents during the reporting period, reflecting its commitment to sustainable development[52]. - The company has not faced any penalties or corrective actions during the reporting period, indicating compliance with regulatory requirements[56]. - The financial report for the first half of 2024 was not audited[85]. Shareholder Information - The company held its first extraordinary shareholders' meeting in 2024 with a participation rate of 67.18%[41]. - The company completed a share buyback of 7,306,128 shares, representing 3.17% of the total share capital, at a total cost of RMB 41,260,216.98[74]. - The total number of shares remains at 230,400,000, with no changes in the shareholding structure[73].